Page last updated: 2024-08-16

technetium tc 99m sestamibi and midazolam

technetium tc 99m sestamibi has been researched along with midazolam in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ackland, SP; Balleine, RL; Blair, EY; Clarke, CL; Collins, M; Evans, S; Farlow, D; Garg, MB; Gurney, H; Hoskins, JM; Mann, GJ; McLachlan, AJ; Rivory, LP; Wong, M1
Balakrishnar, B; Bennink, RJ; Daali, Y; Eechoute, K; Gurney, H; Huitema, AD; Kam, BL; Kloth, JS; Klümpen, HJ; Mathijssen, RH; Samer, CF; Schellens, JH; Wong, M; Yu, H; Zwinderman, AH1

Other Studies

2 other study(ies) available for technetium tc 99m sestamibi and midazolam

ArticleYear
Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Jun-01, Volume: 24, Issue:16

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Body Size; Body Surface Area; Bone Marrow; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Feasibility Studies; Female; Genotype; Humans; Male; Midazolam; Middle Aged; Multivariate Analysis; Neoplasms; Phenotype; Polymorphism, Single Nucleotide; Predictive Value of Tests; Technetium Tc 99m Sestamibi; Vinblastine; Vinorelbine

2006
Predictive value of CYP3A and ABCB1 phenotyping probes for the pharmacokinetics of sunitinib: the ClearSun study.
    Clinical pharmacokinetics, 2014, Volume: 53, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Biotransformation; Cytochrome P-450 CYP3A; Female; Humans; Hypnotics and Sedatives; Indoles; Male; Midazolam; Middle Aged; Phenotype; Prospective Studies; Pyrroles; Radiopharmaceuticals; Sunitinib; Technetium Tc 99m Sestamibi

2014